Vaxart, Inc. (VXRT)
0.6791
+0.07
(+11.34%)
USD |
OTCM |
May 21, 16:00
Vaxart Research and Development Expense (TTM) : 200.24M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 50.82M |
| Capricor Therapeutics, Inc. | 91.90M |
| Allogene Therapeutics, Inc. | 119.83M |
| Agenus, Inc. | 69.64M |
| Curis, Inc. | 26.16M |